BUFFALO, N.Y., Sept. 07, 2022 (World NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a major agricultural biotechnology firm devoted to improving upon health and fitness with lessened nicotine tobacco, hemp/cannabis, and hops superior plant systems, today introduced improvements in its management crew as the Business accelerates progress in its minimized nicotine content tobacco company. The Organization declared that Michael Zercher, President and Chief Operating Officer, will depart the Company successful September 30, 2022. John Miller, who potential customers 22nd Century’s tobacco business enterprise workforce, will suppose the tobacco-related duties of the Main Functioning Officer’s purpose, while Main Executive Officer James A. Mish will suppose the title of Company President.
“With extremely effective VLN® pilot success in hand, 22nd Century is growing revenue and setting up rollouts in strategic locations across the United States,” mentioned James A. Mish, chief executive officer of 22nd Century. “In purchase to coordinate all of the crucial things of this growth as well as supplemental prepared industry launches, John Miller, who presently sales opportunities our tobacco solution, advertising and marketing and partnership initiatives, will think comprehensive operational accountability for the tobacco item traces, bringing to bear his extra than 30 yrs of business expertise to immediate a thoroughly integrated countrywide VLN® product sales technique.”
On behalf of the Board of Directors and the full Firm, I thank Mike for his operate at 22nd Century Team, which includes his critical role in aiding carry VLN® by means of the regulatory approach to protected the to start with and only Food and drug administration Modified Danger Tobacco Solution marketing and advertising get ever granted to a flamable cigarette. Mike has also been instrumental in building our first VLN® sector partnerships and prosperous Chicagoland pilot plan,” said Mish. “As a consequence, 22nd Century represents a completely new kind of tobacco organization focused on disrupting the market and, most importantly, encouraging grownup smokers to smoke less. We thank Mike for the outstanding success he has served the Enterprise attain and would like him well in his long term endeavors.”
About 22nd Century Group, Inc.
22nd Century Group, Inc. (Nasdaq: XXII) is a leading agricultural biotechnology business targeted on tobacco hurt reduction, lowered nicotine tobacco and improving health and wellness by way of plant science. With dozens of patents making it possible for it to command nicotine biosynthesis in the tobacco plant, the Enterprise has designed proprietary diminished nicotine information (RNC) tobacco vegetation and cigarettes, which have develop into the cornerstone of the FDA’s Comprehensive Prepare to address the widespread dying and condition brought about by cigarette smoking. The Business been given the first and only Food and drug administration MRTP authorization of a flamable cigarette in December 2021. In tobacco, hemp/cannabis, and hop vegetation, 22nd Century employs fashionable plant breeding technologies, like genetic engineering, gene-editing, and molecular breeding to supply answers for the lifestyle science and customer items industries by generating new, proprietary crops with optimized alkaloid and flavonoid profiles as properly as enhanced yields and worthwhile agronomic features.
Learn additional at xxiicentury.com, on Twitter, on LinkedIn, and on YouTube.
Master much more about VLN® at tryvln.com.
Cautionary Notice Concerning Ahead-Hunting Statements
Except for historic information and facts, all of the statements, expectations, and assumptions contained in this push release are forward-looking statements. Forward-wanting statements normally consist of conditions such as “anticipate,” “believe,” “consider,” “continue,” “could,” “estimate,” “expect,” “explore,” “foresee,” “goal,” “guidance,” “intend,” “likely,” “may,” “plan,” “potential,” “predict,” “preliminary,” “probable,” “project,” “promising,” “seek,” “should,” “will,” “would,” and related expressions. Precise benefits may differ materially from these express or implicit in ahead-on the lookout statements. Critical elements that could induce real effects to differ materially are established forth in “Risk Factors” in the Company’s Once-a-year Report on Kind 10-K submitted on March 1, 2022, and in the Company’s Quarterly Report submitted on August 9, 2022. All facts offered in this launch is as of the day hereof, and the Company assumes no obligation to and does not intend to update these ahead-wanting statements, other than as needed by regulation.
Investor Relations & Media Get in touch with
Mei Kuo
22nd Century Group, Inc.
Director, Communications & Investor Relations
[email protected]
Darrow Associates Investor Relations
Matt Kreps
T: 214-597-8200
[email protected]
